Results 31 to 40 of about 939,582 (302)

Synchronous Multicentric Giant Cell Tumour (GCT)-A Rare Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2014
Giant Cell Tumours (GCT) of bone account for 5% of all primary bone tumours. Multicentric variety is a rare variant of this condition, accounting for less than 1% of all cases and can occur as synchronous or metachronous lesions. We report a 22-year-old
Anshu Shekhar, Gururaj Murgod, Suresh Korlhalli   +2 more
doaj   +1 more source

Management of patients with multiple primary сancer in the practice of a modern oncologist. Case report and literature review

Сибирский онкологический журнал, 2022
The purpose of the study. Multiple primary malignant neoplasms or polyneoplasia are a phenomenon of tumorigenesis and one of the little-studied categories in modern clinical oncology.
D. A. Khlanta, G. P. Gens
doaj   +1 more source

Genetic background of relapsing lymphoid neoplasms : comprehensive genetic characterization of primary - relapse pairs by chromosomal copy number and mutational analysis [PDF]

, 2016
Diffuse large B-cell lymphoma (DLBCL) is the most frequent tumor of the lymphoid system. Standard first line therapy is successful in the majority of cases, however about 30% of DLBCL are either refractory to it or relapse after a period of ...
Juškevičius, Darius
core   +1 more source

Synchronous subungual glomus tumors in the same finger Tumores glômicos subungueais sincrônicos no mesmo dedo

Anais Brasileiros de Dermatologia, 2012
The glomus tumor is an uncommon benign neoplasm of glomus cells. In the majority of the cases it is presented as a solitary painful papule in the subungual region. We report a rare case of a patient with two individual synchronous glomus tumors under the
Nilton Di Chiacchio, Walter Refkalefsky Loureiro, Nilton Gioia Di Chiacchio, Diego Leonardo Bet   +3 more
doaj   +1 more source

Multiple primary malignant neoplasms: Multi-center results from Turkey

, 2012
Purpose: Multiple primary malignant neoplasms (MPMNs) are defined as a diagnosis of two or more independent primary malignancies of different histologies/origins in an individual. The frequency of MPMN is being increasing.
Oksuzoglu, B., Aksoy, S., Benekli, M., Kaplan, M. Ali, Buyukberber, S., Cetin, B., Babacan, N. A., Zengin, N., Kos, T., Ozdemir, N. Y., Uyeturk, U., Karaca, Halit   +11 more
core   +3 more sources

Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis

Breast Cancer Research, 2023
Background Second primary cancer incidence is rising among breast cancer survivors. We examined the risks of non-breast second primaries, in combination and at specific cancer sites, through a systematic review and meta-analysis.
Isaac Allen, Hend Hassan, Eleni Sofianopoulou, Diana Eccles, Clare Turnbull, Marc Tischkowitz, Paul Pharoah, Antonis C. Antoniou   +7 more
doaj   +1 more source

High rate of epidermal growth factor receptor-mutated primary lung cancer in patients with primary breast cancer

Frontiers in Oncology, 2022
BackgroundWith increased survival in breast cancer, resulting from advances in treatment, patients incur the possibility of subsequent primary malignancies, especially lung cancer.
Tianyu Zeng, Hai Xu, Yincheng Liu, Chunxiao Sun, Fan Yang, Yan Liang, Xiang Huang, Ziyi Fu, Ziyi Fu, Wei Li, Yongmei Yin   +10 more
doaj   +1 more source

Clinical observation of patients with primary multiple malignant tumors, including primary multiple melanoma

, 2023
Recently, there has been an increase in the number of patients with primary multiple malignant tumors, which not only affect one or more organs, but also differ in their histological structure.
N. V. Soldatkina, V. E. Kolesnikov, O. K. Bondarenko, Yu. A. Gevorkyan, I. N. Mironenko, A. V. Dashkov   +5 more
core   +1 more source

Synchronous abdominal tumors: is combined laparoscopic surgery in a single approach a safe option?

International Brazilian Journal of Urology
Background and Purpose: Recent advances in cancer treatment have resulted in bet- ter prognosis with impact on patient's survival, allowing an increase in incidence of a second primary neoplasm.
Marcelo Cartapatti, Roberto Dias Machado, Roberto Lodeiro Muller, Wesley J. Magnabosco, Alexandre César Santos, Brian Francis Chapin, Armando Melani, Antonio Talvane, Marcos Tobias-Machado, Eliney Ferreira Faria   +9 more
doaj   +1 more source

Poorly Differentiated Neuroendocrine Carcinoma of Unknown Primary with Metastasis to the Testis: A Case Report

Case Reports in Oncology, 2022
Neuroendocrine neoplasms are rare epithelial neoplasms with neuroendocrine differentiation. Few cases of primary testicular poorly differentiated neuroendocrine carcinomas (PD-NECs) have been reported, and secondary testicular neoplasms are rare.
Momoko Sano, Masaaki Noguchi, Akiyoshi Kinoshita, Mayo Nakamura, Kazuhiko Koike, Masayuki Saruta   +5 more
doaj   +1 more source